WASHINGTON - AstraZeneca PLC may have included "outdated" information from its coronavirus vaccine trial when reporting the results, possibly providing an "incomplete view of the efficacy data," the U.S. National Institute of Allergy and Infectious Diseases said Tuesday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
